Quest Diagnostics Inc (DGX) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, Quest Diagnostics reported revenue of $11.04B, up 11.8% from $9.87B the year before. Net income was $992.0M (a 9.0% net margin), or $8.75 per diluted share. Gross margin was 33.2% and operating margin was 14.1%. Operating activities generated $1.89B of cash, leaving $1.36B of free cash flow. At fiscal year end, Quest Diagnostics held $16.23B in total assets against $9.05B in total liabilities, including $420.0M of cash and equivalents.
Open the full interactive Quest Diagnostics financials → Quarterly statements, key ratios, valuation history and price charts.
Quest Diagnostics Key Stats
| Share Price | $230.46 |
|---|---|
| Market Cap | $25.81B |
| P/E Ratio | 26.3 |
| Revenue YoY Growth | +11.8% |
| 52-Week Range | $170.62 – $246.53 |
| Shares Outstanding | 111.0 million (basic, 2026 Q2) |
Quest Diagnostics Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $9.44B | $10.79B | $9.88B | $9.25B | $9.87B | $11.04B |
| Cost of Goods Sold | $7.47B | $8.41B | $8.46B | $7.99B | $8.53B | $9.48B |
| Gross Profit | $3.63B | $4.21B | $3.43B | $3.05B | $3.24B | $3.67B |
| Operating Income | $1.97B | $2.38B | $1.43B | $1.26B | $1.35B | $1.56B |
| Pre-Tax Income | $1.88B | $2.60B | $1.24B | $1.13B | $1.18B | $1.32B |
| Income Tax | $460.0M | $597.0M | $264.0M | $248.0M | $273.0M | $314.0M |
| Net Income | $1.43B | $2.00B | $946.0M | $854.0M | $871.0M | $992.0M |
| Diluted EPS | $10.47 | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 |
Quest Diagnostics Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.82B | $2.81B | $2.90B | $3.04B |
| Net Income | $245.0M | $245.0M | $252.0M | $320.0M |
| Diluted EPS | $2.16 | $2.17 | $2.24 | $2.84 |
Quest Diagnostics Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.16B | $872.0M | $315.0M | $686.0M | $549.0M | $420.0M |
| Current Assets | $3.06B | $2.74B | $1.90B | $2.37B | $2.39B | $2.38B |
| Total Assets | $14.03B | $13.61B | $12.84B | $14.02B | $16.15B | $16.23B |
| Current Liabilities | $1.78B | $1.75B | $1.55B | $1.81B | $2.17B | $2.28B |
| Total Long-Term Debt | $4.01B | $4.01B | $3.98B | $4.71B | $6.22B | $5.67B |
| Total Liabilities | $7.27B | $7.17B | $6.94B | $7.71B | $9.38B | $9.05B |
| Shareholders' Equity | $6.76B | $6.44B | $5.89B | $6.31B | $6.78B | $7.17B |
Quest Diagnostics Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $2.00B | $2.23B | $1.72B | $1.27B | $1.33B | $1.89B |
| Cash From Investing | -$772.0M | $21.0M | -$543.0M | -$1.06B | -$2.55B | -$631.0M |
| Cash From Financing | -$1.27B | -$2.54B | -$1.73B | $160.0M | $1.08B | -$1.39B |
| Free Cash Flow | $1.59B | $1.83B | $1.31B | $864.0M | $909.0M | $1.36B |
Figures from Quest Diagnostics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Quest Diagnostics financials page for every line item.
Quest Diagnostics Company Profile
| Ticker | DGX |
|---|---|
| Exchange | NYSE |
| Industry | Medical Laboratories (Services) |
| Headquarters | Secaucus, New Jersey |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001022079 |
Frequently Asked Questions
What was Quest Diagnostics' revenue in fiscal 2025?
Quest Diagnostics (DGX) reported revenue of $11.04B for fiscal 2025.
What is Quest Diagnostics' annual revenue history?
Quest Diagnostics' annual revenue by fiscal year: 2020: $9.44B; 2021: $10.79B; 2022: $9.88B; 2023: $9.25B; 2024: $9.87B; 2025: $11.04B.
What was Quest Diagnostics' net income in fiscal 2025?
Quest Diagnostics reported net income of $992.0M for fiscal 2025.
What was Quest Diagnostics' earnings per share (EPS) in fiscal 2025?
Quest Diagnostics' diluted EPS was $8.75 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Quest Diagnostics generate in fiscal 2025?
Quest Diagnostics generated $1.36B of free cash flow in fiscal 2025.
What was Quest Diagnostics' revenue last quarter?
In its most recent reported quarter (2026 Q2), Quest Diagnostics reported revenue of $3.04B.
How much debt does Quest Diagnostics have?
Quest Diagnostics reported $5.67B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Quest Diagnostics are outstanding?
Quest Diagnostics reported a weighted average of 111.0 million basic shares outstanding in 2026 Q2.
What is Quest Diagnostics' market cap?
Based on its latest closing price, Quest Diagnostics (DGX) has a market capitalization of about $25.81B.
When does Quest Diagnostics' fiscal year end?
Quest Diagnostics' fiscal year end, as registered with the SEC, is December 31.
Where is Quest Diagnostics headquartered?
Quest Diagnostics lists its business address in Secaucus, New Jersey in its SEC filings.